Advertisement

Topics

Latest Prostate Cancer research and development NewsRSS

00:09 EDT 17th October 2017 | BioPortfolio

MagForce AG MF6 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102017] Prices from USD $250

SummaryMagForce AG MagForce is a medical device company that offers nanotechnologybased cancer treatment. The company offers treatment for brain tumor and cancer diseases. It provides products such as NanoActivator, NanoTherm, NanoPlan and NanoTherm Therapy. MagForce's product NanoActivator creates a magnetic field that can be used to treat tumors in all areas of the body and NanoTherm is a liquid...

Quest PharmaTech Inc QPT Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102017] Prices from USD $250

SummaryQuest PharmaTech Inc Quest, formerly Altachem Pharma Ltd is a biotechnology company that develops and commercializes oncology product candidates. The company provides products for chemotherapy, photodynamic therapy and immunoadjuvants; and offers series of monoclonal antibodies for different cancer markers. It provides products such as anti CA125 MAb oregovomab, anti MUC1 MAb AR20.5 and SL0...

Polaris Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14092017] Prices from USD $250

SummaryPolaris Pharmaceuticals Inc Polaris is a biopharmaceutical company that conducts research and development of protein drugs for the treatment of cancer and other enervating diseases. The company's ADIPEG 20, is a biotherapeutic agent which is being assessed in crucial Phase III clinical trials for the treatment of hepatocellular carcinoma. It also provides treatment for argininedependent can...

PROMETRIKA to Coordinate Second Phase I Trial for MD Anderson’s Institute for Applied Cancer Science

Cambridge, MA-based clinical research organization to manage Phase 1 advanced solid tumors and lymphoma study. PROMETRIKA, LLC, a boutique full service Clinical Research Organization (CRO), is coordinating a Phase 1 trial for The University of Texas MD Anderson Cancer Center’s Institute for Applie

Onco360 Selected for VERZENIO® Limited Distribution Pharmacy Network

Onco360, the nation’s largest independent Oncology Pharmacy, announced today that it has been selected to participate in the limited distribution network for Eli Lilly and Company’s new product, VERZENIOTM (Abemaciclib), a twice daily oral cyclin-dependent kinase (CDK) 4/6 inhibitor approved by the U.S. Food and Drug Administration (FDA). VERZENIO is u...

All cancer care needs to consider the whole patient

An excerpt from Cancer What You Need to Know. Treating cancer means taking care of the whole patient — the physical, the emotional, and the spiritual. This starts at diagnosis and carries through treatment and beyond. Unfortunately, for some patients, cancer does find ways to spread that can cause physical pain, emotional strain, and difficulties in […]

Methionine Aminopeptidase 2 Initiation Factor 2 Associated 67 kDa Glycoprotein or Peptidase M 2 or eIF 2 Associated p67 Homolog or METAP2 or EC 3.4.11.18 Pipeline Review, H2 2017 [Report Updated: 30092017] Prices from USD $3500

Methionine Aminopeptidase 2 Initiation Factor 2 Associated 67 kDa Glycoprotein or Peptidase M 2 or eIF 2 Associated p67 Homolog or METAP2 or EC 3.4.11.18 Pipeline Review, H2 2017SummaryAccording to the recently published report 'Methionine Aminopeptidase 2 Pipeline Review, H2 2017'; Methionine Aminopeptidase 2 Initiation Factor 2 Associated 67 kDa Glycoprotein or Peptidase M 2 or eIF 2 Associate...

Cancer drugs could be grown in chicken eggs

Hazy Cancer–Sugar Association Becomes Clearer

For those with a tendency toward the conspiratorial, this is not a takedown about how “Big Sugar” is poisoning the world and increasing cancer rates. Instead, new evidence from a collaborative team of Belgian researchers at the University of Leuven (KU Leuven), the University of Brussels (VUB), and the Vlaams Institute for Biotechnology (VIB) has clarified how the Warburg effect—a phenomenon...

NanOlogy™ Announces First Patient Enrolled in a Phase 2 Clinical Trial of NanoPac® for Treatment of Prostate Cancer

NanOlogy to Present at BIO Investor Forum on October 17 in San Francisco NanOlogy LLC, a clinical-stage pharmaceutical development company, today announced the first patient has been enrolled in a

Progenics Pharmaceuticals Announces Presentations on AZEDRA® (iobenguane I 131) and its Prostate Cancer Programs at the 30th Annual Congress of the European Association of Nuclear Medicine

NEW YORK, Oct. 16, 2017 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, announced today that data from several of the Company’s development programs will be presented in oral sessions at the 30th Annual Congress of the European Association of Nuclear Medicin...

Inovio Pharmaceuticals Begins Phase 1b/2 Cancer Efficacy Trial Combining Its T-cell Immunotherapy with a PD-L1 Checkpoint Inhibitor in Advanced Bladder Cancer

PLYMOUTH MEETING, Pa., Oct. 16, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced initiation of a phase 1b/2 immuno-oncology trial to evaluate Genentech/Roche’s atezolizumab (TECENTRIQ®) in combination with Inovio’s INO-5401, a T cell activating immunotherapy encoding multiple antigens, and INO-9012, an immune activator encoding IL-12. The multi-center,...

Global Specific Cancer Immunotherapy Drugs Market Research Report Forecast 2017 to 2021 [Report Updated: 18092017] Prices from USD $2800

The Global Specific Cancer Immunotherapy Drugs Market Research Report Forecast 20172021 is a valuable source of insightful data for business strategists. It provides the Specific Cancer Immunotherapy Drugs industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research analysts provide an elaborate description of the value chain a...

Fred Hutchinson Cancer Research Center Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17082017] Prices from USD $250

SummaryFred Hutchinson Cancer Research Center Fred Hutchinson, a subsidiary of National Comprehensive Cancer Network, is a nonprofit organization which conducts research on the prevention, diagnose and treatment of cancer, HIV/AIDS and other life threatening diseases. It conducts research on various diseases such as cervical cancer, colorectal cancer, crohn's disease, cystic fibrosis, esophageal c...

Global Cancer Angiogenesis Inhibitor Market Research Report Forecast 2017 to 2022 [Report Updated: 09102017] Prices from USD $2800

Delivery of the Report will take 23 working days once order is placed.The Global Cancer Angiogenesis Inhibitor Market Research Report Forecast 20172022 is a valuable source of insightful data for business strategists. It provides the Cancer Angiogenesis Inhibitor industry overview with growth analysis and historical futuristic cost, revenue, demand and supply data as applicable. The research anal...

MenoGeniX Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13092017] Prices from USD $250

SummaryMenoGeniX Inc MenoGeniX is a biotechnology company with a focus on development for menopausal women and cancer patients. Its pipeline product portfolio include MNGX100, is under Phase 1b human clinical trial. The company's therapeutic agents are developed for new indications, such as menopause, and the menopauselike symptoms in menopausal women and also in certain breast and prostate cancer...

Lidds AB LIDDS Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17082017] Prices from USD $250

SummaryLidds AB Lidds is a pharmaceutical company that develops pharmaceutical products based on medical need and proprietary drug delivery technology. The company's product includes Liproca Depot kit, an injectable product used for the treatment of prostate cancer. Its Liproca is a novel bioresorbable, biocompatible and locally injectable modified release formulation of 2hydroxyflutamid that is p...

Alternative medicine for cancer: Greater scrutiny is needed

As the calendar turns to early October, I’m reminded that this is the 6th anniversary of Steve Jobs’ death. At the time of his death, I was a medical student and my wife had just completed six months of chemotherapy. I was surprised to learn that Jobs had died from complications of cancer and shocked […]

OBI Pharma Inc 4174 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17082017] Prices from USD $250

SummaryOBI Pharma Inc OBI Pharma is a developer of therapies for the treatment of cancer and infectious diseases. The company develops its pipeline products through its carbohydrate synthesis discovery platform. Its flagship products include OBI822, an active immunotherapy which is intended for the treatment of metastatic breast cancer. OBI Pharma also develops of active immunotherapies intended f...

Cholesterol byproduct encourages spread of breast cancer, metastasis

#jobs #lifescience Postdoctoral Research Fellow Translational Research in Breast Cancer

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Postdoctoral Research Fellow Translational Research in Breast Cancer .Translational Research in Breast Cancer The laboratory of Carlos L. Arteaga, MD in the Harold C. Simmons Comprehensive Cancer Center … Continue reading → Cet article #jobs #lifescience Postdoctor...

GP Pharm SA Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17082017] Prices from USD $250

SummaryGP Pharm SA GP Pharm is a biopharmaceutical company that develops and markets injectables in the areas of oncology and urology. The company's product portfolio includes injectable dosage forms for the treatment of advanced prostate cancer; nocturnal enuresis and central diabetes insipidus; endometriosis, women fertility and precocious puberty, among others. It offers products for acromegaly...

RCC Subtypes Affect Post-Surgery Cancer-Related Mortality Risk

Patients with papillary versus clear cell renal cell carcinoma have a 24% decreased risk of dying from their cancer.

PANDORA Turns Pink for a Good Cause

October is internationally recognised as Breast Cancer Awareness month, and PANDORA supports the cause through various local charitable initiatives across the world. SOURCE: PANDORA DESCRIPTION:Across the world, October is recognised as Breast Cancer Awareness (BCA) month. As a brand with a big heart and a history of supporting women through charitable causes, PANDORA is donating to the cause in v...

Vantage Oncology Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14092017] Prices from USD $250

SummaryVantage Oncology Inc Vantage Oncology, a subsidiary of McKesson Corp is a critical oncology service provider that owns and operates cancer treatment facilities. The company operates cancer treatment facilities in the US. It provides treatment for bone, brain, breast, gastrointestinal, gynecological, prostate, skin, and lung cancer. Vantage Oncology's medical oncology includes initial consul...

Quick Search
Advertisement
 

review and buy Prostate Cancer research and development market research data and corporate reports here